Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias

Current Neuropharmacology

Volumn 11, Issue 1, 2013, Pages 30-40

  Casper, Catharina ^a   Kalliolia, Eirini ^a   Warner, Thomas T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dystonia plus syndrome; Mitochondria; Molecular pathogenesis; Neurodegeneration; Secondary dystonia

Indexed keywords

CYTOCHROME C OXIDASE; DOPAMINE; DOPAMINE TRANSPORTER; EPSILON SARCOGLYCAN; LEVODOPA; REACTIVE OXYGEN METABOLITE; SEROTONIN; TETRAHYDROBIOPTERIN;

APOPTOSIS; CELLULAR STRESS RESPONSE; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC NERVE CELL; DYSTONIA; EXERCISE; GENE EXPRESSION; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; LESCH NYHAN SYNDROME; LOW DRUG DOSE; MOLECULAR PATHOLOGY; MOTOR DYSFUNCTION; MYOCLONUS DYSTONIA; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PARKINSONISM; PHENOTYPE; REVIEW;

EID: 84874887082     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015913804999432     Document Type: Review

References (87)

1. Phukan, J., Albanese, A., Gasser, T., and Warner, T. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol. 2011, 10, 1074-1085.
2. Trender-Gerhard, I., Sweeney, M.G., Schwingenschuh, P., Mir, P., Edwards, M.J., Gerhard, A., Polke, J.M., Hanna, M.G., Davis, M.B., Wood, N.W. Bhatia, K. P. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J. Neurol. Neurosurg. Psychiatry, 2009, 80, 839-845.
3. Van Hove, J.L., Steyaert, J., Matthijs, G., Legius, E., Theys, P., Wevers, R., Romstad, A., Moller, L.B., Hedrich, K., Goriounov, D. Blau, N., Klein, C., Casaer, P. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J. Neurol. Neurosurg. Psychiatry, 2006, 77, 18-23.
4. Clot, F., Grabli, D., Cazeneuve, C., Roze, E., Castelnau, P., Chabrol, B., Landrieu P., Nguyen, K., Ponsot, G., Abada, M. Diane, D., Philippe, D., Roger, G., Stéphane, T., Alana, J. W., Michael, H., Annick, T., Fabienne, P., Agnès, C., Estelle, F., Chankannira, S., Delphine, B., Eric, LeGuern., Alexandra, D., Marie, V., Alexis, B. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain, 2009, 132, 1753-1763.
5. Furukawa, Y., Nygaard, T.G., Gütlich, M., Rajput, A.H., Pifl, C., DiStefano, L., Chang, L.J., Price, K., Shimadzu, M., Hornykiewicz, O., Haycock, J.W., Kish, S.J. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology, 1999, 53, 1032-1041.
6. Segawa, M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev. 2000, 22 Suppl 1, S65-S80.
7. Ling, H., Polke, J.M., Sweeney, M.G., Haworth, A., Sandford, C.A., Heales, S.J., Wood. N.W., Davis, M.B., and Lees, A.J. An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family. Mov. Disord. 2011, 26, 905-909.
8. Koenig, M.K. and Butler, I.J. Tetrahydrobiopterin Deficiency Oxidative Stress and Free Radical Damage in Neurology. Gadoth N, G+Âbel HH, eds. Humana Press. 2011 pp. 225-234.
9. Roze, E., Apartis, E., Clot, F., Dorison, N., Thobois, S., Guyant-Marechal L., Tranchant, C., Damier, P., Doummar, D., Bahi-Buisson N. André-Obadia, N., Maltete, D., Echaniz-Laguna, A., Pereon, Y., Beaugendre, Y., Dupont, S., De Greslan, T. Jedynak, C. P., Ponsot, G., Dussaule, J. C., Brice, A., Dürr, A. and Vidailhet, M. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology, 2008, 70, 1010-1016.
10. Asmus, F., Langseth, A., Doherty, E., Nestor, T., Munz, M., Gasser, T., Lynch, T., and King, M.D. "Jerky" dystonia in children: spectrum of phenotypes and genetic testing. Mov. Disord. 2009, 24, 702-709.
11. Azoulay-Zyss, J., Roze, E., Welter, M.L., Navarro, S., Yelnik, J., Clot, F., Bardinet, E., Karachi, C., Dormont, D., Galanaud, D. Azoulay-Zyss, J., Roze, E., Welter, M.L. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilonsarcoglycan mutations: a pilot study. Arch. Neurol. 2011, 68, 94-98.
12. Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Muller-Myhsok, B. Leonhard, R., Matthias, B., Tanja, M., Mirna, C., Thomas, M., Tim, M. S., Thomas, G. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat. Genet. 2001, 29, 66-69.
13. Grabowski, M., Zimprich, A., Lorenz-Depiereux, B., Kalscheuer, V., Asmus, F., Gasser, T., Meitinger, T., and Strom, T.M. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur. J. Hum. Genet. 2003, 11, 138-144.
14. Muller, B., Hedrich, K., Kock, N., Dragasevic, N., Svetel, M., Garrels, J., Landt, O., Nitschke, M., Pramstaller, P.P., Reik, W. Leonhard, R., Matthias, B., Tanja, M., Mirna, C., Thomas, M., Tim, M. S., Thomas, G., Birgitt, M., Katja, H., Norman, K., Natasa, D., Marina, S.J.G., Olfert, L., Matthias, N., Peter, P. Pramstaller., Wolf, R., Eberhard, S., Jürgen, S., Laurie, O., Vladimir, K., Christinem, K. Evidence that paternal expression of the epsilonsarcoglycan gene accounts for reduced penetrance in myoclonusdystonia. Am. J. Hum. Genet. 2002, 71, 1303-1311.
15. Asmus, F. and Gasser, T. Dystonia-plus syndromes. Eur. J. Neurol. 2010, 17 Suppl 1, 37-45.
16. Chan, P., Gonzalez-Maeso, J., Ruf, F., Bishop, D.F., Hof, P.R., and Sealfon, S.C. Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J. Comp. Neurol. 2005, 482, 50-73.
17. Bozic, D., Sciandra, F., Lamba, D., and Brancaccio, A. The structure of the N-terminal region of murine skeletal muscle alphadystroglycan discloses a modular architecture. J. Biol. Chem. 2004, 279, 44812-44816.
18. Dickens, N.J., Beatson, S., and Ponting, C.P. Cadherin-like domains in alpha-dystroglycan, alpha/epsilon-sarcoglycan and yeast and bacterial proteins. Curr. Biol. 2002, 12, R197-R199.
19. Esapa, C.T., Waite, A., Locke, M., Benson, M.A., Kraus, M., McIlhinney, R.A., Sillitoe, R.V., Beesley, P.W., and Blake, D.J. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum. Mol. Genet. 2007, 16, 327-342.
20. Waite, A., De Rosa, M.C., Brancaccio, A., and Blake, D.J. A gainof-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse epsilonsarcoglycan in the late secretory pathway. Hum. Mutat. 2011, 32, 1246-1258.
21. Yokoi, F., Dang, M.T., Yang, G., Li, J., Doroodchi, A., Zhou, T., and Li, Y. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models. Behav. Brain Res. 2012, 227, 12-20.
22. Goodchild, R.E. and Dauer, W.T. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 847-852.
23. Hubsch, C., Vidailhet, M., Rivaud-Pechoux, S., Pouget, P., Brochard, V., Degos B., Pelisson, D., Golmard, J.L., Gaymard, B., and Roze, E. Impaired saccadic adaptation in DYT11 dystonia. J. Neurol. Neurosurg. Psychiatry 2011, 82, 1103-1106.
24. Yokoi, F., Dang, M.T., Zhou, T., and Li, Y. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonusdystonia mouse models. Hum. Mol. Genet. 2012, 21, 916-925.
25. Beukers, R.J., van der Meer, J.N., van der Salm, S.M., Foncke, E.M., Veltman, D.J., and Tijssen, M.A. Severity of dystonia is correlated with putaminal gray matter changes in Myoclonus-Dystonia. Eur. J. Neurol., 2011, 18, 906-912.
26. Dobyns, W.B., Ozelius, L.J., Kramer, P.L., Brashear, A., Farlow, M.R., Perry, T.R., Walsh, L.E., Kasarskis, E.J., Butler, I.J., and Breakefield, X.O. Rapid-onset dystonia-parkinsonism. Neurology, 1993, 43, 2596-2602.
27. +-ATPase-3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron, 2004, 43, 169-175.
28. Brashear, A., DeLeon, D., Bressman, S.B., Thyagarajan, D., Farlow, M.R., and Dobyns, W.B. Rapid-onset dystoniaparkinsonism in a second family. Neurology, 1997, 48, 1066-1069.
29. Pittock, S.J., Joyce, C., O'Keane, V., Hugle, B., Hardiman, M.O., Brett, F., Green, A.J., Barton, D.E., King, M.D., and Webb, D.W. Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology 2000, 55, 991-995.
30. Kaplan, J.H. Biochemistry of Na, K-ATPase. Annu. Rev. Biochem. 2002, 71, 511-535.
31. Richards K.S., Bommert, K., Szabo, G., and Miles, R. Differential expression of Na+/K+-ATPase alpha-subunits in mouse hippocampal interneurones and pyramidal cells. J. Physiol., 2007, 585, 491-505.
32. Ashmore, L.J., Hrizo, S.L., Paul, S.M., Van Voorhies, W.A., Beitel, G.J., and Palladino, M.J. Novel mutations affecting the Na, K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity. Hum. Genet. 2009, 126, 431-447.
33. DeAndrade, M.P., Yokoi, F., van G.T., Lingrel, J.B., and Li, Y. Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav. Brain Res. 2011, 216, 659-665.
34. Calderon, D.P., Fremont, R., Kraenzlin, F., and Khodakhah, K. The neural substrates of rapid-onset Dystonia-Parkinsonism. Nat. Neurosci. 2011, 14, 357-365.
35. Camargos, S., Scholz, S., Simon-Sanchez, J., Paisan-Ruiz, C., Lewis, P., Hernandez, D., Ding, J., Gibbs, J.R., Cookson, M.R., Bras, J. Rita, G., Catarina, R. O., Andrew, L., John, H., Francisco, C., Andrew, B. S. DYT16, a novel young-onset dystoniaparkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol. 2008, 7, 207-215.
36. Camargos, S., Lees, A.J., Singleton, A., and Cardoso, F. DYT16: the original cases. J. Neurol. Neurosurg. Psychiatry, 2012, 83(10), 1012-4.
37. Seibler, P., Djarmati, A., Langpap, B., Hagenah, J., Schmidt, A., Brüggemann, N., Siebner, H., Jabusch, H.C., Altenmüller, E., Münchau, A., Lohmann, K., Klein, C. A heterozygous frameshift mutation in PRKRA (DYT16) associated with generalised dystonia in a German patient. Lancet Neurol. 2008, 7, 380-381.
38. de Carvalho, A. P.M. and Ozelius, L.J. Classification and genetics of dystonia. Lancet Neurol. 2002, 1, 316-325.
39. Brashear, A., Dobyns, W.B., de Carvalho, A.P., Borg, M., Frijns, C.J., Gollamudi S., Green, A., Guimaraes, J., Haake, B.C., Klein, C. Gurutz, L., Alexander, M., Deborah, R., David, R., Rachel, Saunders-Pullman., Marina, A. J. T., David, W., Jacek, Z., Susan, B. B., Laurie, J. O. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain, 2007, 130, 828-835.
40. Donze, O., Dostie, J., and Sonenberg, N. Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology, 1999, 256, 322-329.
41. Bennett, R.L., Blalock, W.L., Choi, E.J., Lee, Y.J., Zhang, Y., Zhou, L., Oh, S.P., and May, W.S. RAX is required for fly neuronal development and mouse embryogenesis. Mech. Dev. 2008, 125, 777-785.
42. Onuki, R., Bando, Y., Suyama, E., Katayama, T., Kawasaki, H., Baba, T., Tohyama, M., and Taira, K. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 2004, 23, 959-968.
43. Paquet, C., Bose, A., Polivka, M., Peoc'h, K., Brouland, J.P., Keohane, C., Hugon J., and Gray, F. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 2009, 68, 190-198.
44. Romano, P.R., Zhang, F., Tan, S.L., Garcia-Barrio, M.T., Katze, M.G., Dever, T.E., and Hinnebusch, A.G. Inhibition of doublestranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell Biol. 1998, 18, 7304-7316.
45. Peters, G.A., Dickerman, B., and Sen, G.C. Biochemical analysis of PKR activation by PACT. Biochemistry, 2009, 48, 7441-7447.
46. Peters, G.A., Hartmann, R., Qin, J., and Sen, G.C. Modular structure of PACT: distinct domains for binding and activating PKR. Mol. Cell Biol. 2001, 21, 1908-1920.
47. Daher, A., Laraki, G., Singh, M., Melendez-Pena, C.E., Bannwarth, S., Peters, A.H., Meurs, E.F., Braun, R.E., Patel, R.C., and Gatignol, A. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol. Cell Biol. 2009, 29, 254-265.
48. Singh, M., Castillo, D., Patel, C.V., and Patel, R.C. Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation. Biochemistry, 2011, 50, 4550-4560.
49. Singh, M. and Patel, R.C. Increased interaction between PACT molecules in response to stress signals is required for PKR activation. J. Cell Biochem. 2012, 113, 2754-2764.
50. Huang, X., Hutchins, B., and Patel, R.C. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem. J. 2002, 366, 175-186.
51. Lesch, M. and Nyhan, W.L. A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med. 1964, 36, 561-570.
52. Jinnah H.A., Lewis, R.F., Visser, J.E., Eddey, G.E., Barabas, G., and Harris, J.C. Ocular motor dysfunction in Lesch-Nyhan disease. Pediatr. Neurol. 2001, 24, 200-204.
53. Puig, J.G., Torres, R.J., Mateos, F.A., Ramos, T.H., Arcas, J.M., Buno, A.S., and O'Neill, P. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine (Baltimore) 2001, 80, 102-112.
54. Jinnah, H.A., Visser, J.E., Harris, J.C., Verdu, A., Larovere, L., Ceballos-Picot, I., Gonzalez-Alegre, P., Neychev, V., Torres, R.J., Dulac, O. Isabelle, D., David, J., Schretlen, K. L., Robey, G. B., Bastiaan, R. B., William, N., Raquel, De Kremer., Gary, E. E., Juan, G. P., Stephen, G. R. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006, 129, 1201-1217.
55. Nyhan W.L. Behavior in the Lesch-Nyhan syndrome. J. Autism Child Schizophr. 1976, 6, 235-252.
56. Anderson, L.T. and Ernst, M. Self-injury in Lesch-Nyhan disease. J. Autism Dev. Disord. 1994, 24, 67-81.
57. Schretlen, D.J., Ward, J., Meyer, S.M., Yun, J., Puig, J.G., Nyhan, W.L., Jinnah, H.A., and Harris, J.C. Behavioral aspects of Lesch-Nyhan disease and its variants. Dev. Med. Child Neurol. 2005, 47, 673-677.
58. Schretlen, D.J., Harris, J.C., Park, K.S., Jinnah, H.A., and del Pozo, N.O. Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. J. Int. Neuropsychol. Soc. 2001, 7, 805-812.
59. Matthews W.S., Solan, A., and Barabas, G. Cognitive functioning in Lesch-Nyhan syndrome. Dev. Med. Child Neurol. 199537, 715-722.
60. Nyhan W.L., O'Neill J.P., Jinnah, H.A., and Harris, J.C. Lesch-Nyhan Syndrome. 1993
61. Mak, B.S., Chi, C.S., Tsai, C.R., Lee, W.J., and Lin, H.Y. New mutations of the HPRT gene in Lesch-Nyhan syndrome. Pediatr. Neurol. 2000, 23, 332-335.
62. Ernst, M., Zametkin, A.J., Matochik, J.A., Pascualvaca, D., Jons, P.H., Hardy, K., Hankerson, J.G., Doudet, D.J., and Cohen, R.M. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N. Engl. J. Med. 1996, 334, 1568-1572.
63. Ceballos-Picot, I., Mockel, L., Potier, M.C., Dauphinot, L., Shirley, T.L., Torero-Ibad, R., Fuchs, J., and Jinnah, H.A. Hypoxanthineguanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis. Hum. Mol. Genet. 2009, 18, 2317-2327.
64. Brunet, I., Di Nardo, A.A., Sonnier, L., Beurdeley, M., and Prochiantz, A. The topological role of homeoproteins in the developing central nervous system. Trends Neurosci. 2007, 30, 260-267.
65. Di Nardo, A.A., Nedelec, S., Trembleau, A., Volovitch, M., Prochiantz, A., and Montesinos, M.L. Dendritic localization and activity-dependent translation of Engrailed1 transcription factor. Mol. Cell Neurosci. 2007, 35, 230-236.
66. Cristini, S., Navone, S., Canzi, L., Acerbi, F., Ciusani, E., Hladnik, U., de G.P., Alessandri, G., Colombo, A., Parati, E., Gloria, I. Human neural stem cells: a model system for the study of Lesch-Nyhan disease neurological aspects. Hum. Mol. Genet. 2010, 19, 1939-1950.
67. Kurian, M.A., Zhen, J., Cheng, S.Y., Li, Y., Mordekar, S.R., Jardine, P., Morgan, N.V., Meyer, E., Tee, L., Pasha, S. Evangeline, W., Simon, J.R., Heales, P., Gissen, M.E. Reith, A., Eamonn, M, R. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J. Clin. Invest. 2009, 119, 1595-1603.
68. Kurian, M.A., Li, Y., Zhen, J., Meyer, E., Hai, N., Christen, H.J., Hoffmann, G.F., Jardine, P., von, M.A., Mordekar, S.R. Finbar, O'C., Evangeline, W., Elizabeth, W., Christa, D., Timothy, L., Keith, H., Simon, J.R., Heale, S., Terence, S., Paul G., Birgit, E.A., Maarten, E.A.R., Eamonn, R. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol. 2011, 10, 54-62.
69. Yu-Wai-Man, P., Griffiths, P.G., Hudson, G., and Chinnery, P.F. Inherited mitochondrial optic neuropathies. J. Med. Genet. 2009, 46, 145-158.
70. Ghelli, A., Zanna, C., Porcelli, A.M., Schapira, A.H., Martinuzzi, A., Carelli, V., and Rugolo, M. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J. Biol. Chem. 2003, 278, 4145-4150.
71. Giordano, C., Montopoli, M., Perli, E., Orlandi, M., Fantin, M., Ross-Cisneros, F.N., Caparrotta, L., Martinuzzi, A., Ragazzi, E., Ghelli, A. Alfredo, A. S., Giulia d', A., Valerio, C. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain, 2011, 134, 220-234.
72. Korsten, A., de Coo, I.F., Spruijt, L., de Wit, L.E., Smeets, H.J., and Sluiter, W. Patients with Leber hereditary optic neuropathy fail to compensate impaired oxidative phosphorylation. Biochim. Biophys. Acta 2010, 1797, 197-203.
73. Engl, G., Florian, S., Tranebjaerg, L., and Rapaport, D. Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology. Hum. Mol. Genet. 2012, 21, 287-299.
74. Zhu, Z., Yao, J., Johns, T., Fu, K., De B., I, Macmillan, C., Cuthbert, A.P., Newbold, R.F., Wang, J., Chevrette, M. Garry, K, B., Ruth, M.B., Eric, A. S. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat. Genet. 1998, 20, 337-343.
75. Rahman, S., Brown, R.M., Chong, W.K., Wilson, C.J., and Brown, G.K. A SURF1 gene mutation presenting as isolated leukodystrophy. Ann. Neurol. 2001. 49, 797-800.
76. Santoro, L., Carrozzo, R., Malandrini, A., Piemonte, F., Patrono, C., Villanova M., Tessa, A., Palmeri, S., Bertini, E., and Santorelli, F.M. A novel SURF1 mutation results in Leigh syndrome with peripheral neuropathy caused by cytochrome c oxidase deficiency. Neuromuscul. Disord. 2000, 10, 450-453.
77. Tiranti, V., Hoertnagel, K., Carrozzo, R., Galimberti, C., Munaro, M., Granatiero, M., Zelante, L., Gasparini, P., Marzella, R., Rocchi, M. Bayona-Bafaluy, M. P., Enriquez, J. A., Uziel, G., Bertini, E., Dionisi-Vici, C., Franco, B., Meitinger, T., and Zeviani, M. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 1998, 63, 1609-1621.
78. Schmiedel, J., Jackson, S., Schafer, J., and Reichmann, H. Mitochondrial cytopathies. J. Neurol. 2003, 250, 267-277.
79. Ngu, L.H., Nijtmans, L.G., Distelmaier, F., Venselaar, H., van Emst-de Vries, S.E., van den Brand, M.A., Stoltenborg, B.J., Wintjes, L.T., Willems, P.H., van den Heuvel, L.P. Smeitink, J.A., Rodenburg, R.J. A catalytic defect in mitochondrial respiratory chain complex I due to a mutation in NDUFS2 in a patient with Leigh syndrome. Biochim. Biophys. Acta 2012, 1822, 168-175.
80. Verkaart, S., Koopman, W.J., van Emst-de Vries, S.E., Nijtmans, L.G., van den Heuvel, L.W., Smeitink, J.A., and Willems, P.H. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim. Biophys. Acta 2007, 1772, 373-381.
81. Stettner, G.M., Viscomi, C., Zeviani, M., Wilichowski, E., and Dutschmann, M. Hypoxic and hypercapnic challenges unveil respiratory vulnerability of Surf1 knockout mice, an animal model of Leigh syndrome. Mitochondrion, 2011, 11, 413-420.
82. Prabhakar, N.R., Peng, Y.J., Yuan, G., and Kumar, G.K. Reactive oxygen species facilitate oxygen sensing. Novartis. Found. Symp. 2006, 272, 95-99.
83. Granata, A., Watson, R., Collinson, L.M., Schiavo, G., and Warner, T.T. The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J. Biol. Chem. 2008, 283, 7568-7579.
84. Granata, A., Koo, S.J., Haucke, V., Schiavo, G., and Warner, T. TCSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process. EMBO J, 2011, 30, 181-193.
85. Bragg, D.C., ArmataI, A., Nery, F.C., Breakefield, X.O., and Sharma, N. Molecular pathways in dystonia. Neurobiol. Dis. 2011, 42, 136-147.
86. Schapira, A.H., Warner, T., Gash, M.T., Cleeter, M.W., Marinho, C.F., and Cooper, J.M. Complex I function in familial and sporadic dystonia. Ann. Neurol. 1997, 41, 556-559.
87. Niethammer, M., Carbon, M., Argyelan, M., and Eidelberg, D. Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiol. Dis. 2011, 42, 202-209.